from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2073c/-

LFCtreatmentdescriptionclass of inhibitor

-0.367

Amikacinug/mL Amikacintranslation

-0.446

Cap5-10ug/mL Capreomycintranslation

0.540

Rox10-50 ug/mL Roxithromycintranslation

-0.822

SM2-5 ug/mL Streptomycintranslation

-0.200

Tet5-10 ug/mL Tetracyclinetranslation

1.095

Rif0.2-5ug/mL Rifampicintranscription

0.369

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.451

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.311

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.091

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.575

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.661

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.492

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.174

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.828

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.077

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.053

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.408

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.310

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.313

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.020

KCN5-20 ug/mL Potassium cyaniderespiration

-0.371

NaN30.2-2 mM Sodium aziderespiration

-0.601

Nigericin50 uM Nigericinrespiration

0.703

TRC10-150 ug/mL Triclosanrespiration

-0.455

TRZ10-25 ug/mL Thioridazinerespiration

1.018

Valinomycin0.5-10 uM Valinomycinrespiration

-1.609

ZnSO42 mM ZnSO4respiration

0.531

menadione6-10 ug/mL Menadionerespiration

0.268

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.311

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.171

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.006

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.529

NRP_1Non-replicating persistence stage 1dosRassociated

-0.398

Amp0.2mg/mL AmpicillincellWall

-0.099

Cephalexin20-100 ug/mL CephalexincellWall

-0.401

Cerulenin0.32-5 ug/mL CerulenincellWall

0.591

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.437

EMB10-20 ug/mL EthambutolcellWall

-0.817

Eta12-40 ug/mL EthionamidecellWall

-0.408

INH0.2-0.4 ug/mL IsoniazidcellWall

0.049

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.131

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.975

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.047

BZA0.12 mg/mL BenzamidearomaticAmides

0.174

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.358

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.922

H2O24 mM hydrogen peroxideDNAdamaging

-0.135

Levo10 ug/mL LevofloxacinDNAdamaging

0.017

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.530

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.401

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.022

UVUV-irradiationDNAdamaging

0.142

ARP41-4 ug/mL Antitubercular compound ARP4?

0.203

Antimycin12.5-50 ug/mL Antimycin A?

-0.126

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.619

PA_110-50 ug/mL Antitubercular compound PA-1?

0.443

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.050

PA8240.2-2 ug/mL PA-824?

0.375

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.639

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.589

Verapamil50 uM Verapamil?

0.699

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.078

methoxatin10-20 ug/mL Methoxatin?